Phytochemicals in prostate cancer: From bioactive molecules to upcoming therapeutic agents

Bahare Salehi, Patrick Valere Tsouh Fokou, Lauve Rachel Tchokouaha Yamthe, Brice Tchatat Tali, Charles Oluwaseun Adetunji, Amirhossein Rahavian, Fhatuwani Nixwell Mudau, Miquel Martorell, William N. Setzer, Célia F. Rodrigues, Natália Martins, William C. Cho, Javad Sharifi-Rad

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

89 Citas (Scopus)

Resumen

Prostate cancer is a heterogeneous disease, the second deadliest malignancy in men and the most commonly diagnosed cancer among men. Traditional plants have been applied to handle various diseases and to develop new drugs. Medicinal plants are potential sources of natural bioactive compounds that include alkaloids, phenolic compounds, terpenes, and steroids. Many of these naturally-occurring bioactive constituents possess promising chemopreventive properties. In this sense, the aim of the present review is to provide a detailed overview of the role of plant-derived phytochemicals in prostate cancers, including the contribution of plant extracts and its corresponding isolated compounds.

Idioma originalInglés
Número de artículo1483
PublicaciónNutrients
Volumen11
N.º7
DOI
EstadoPublicada - jul. 2019
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Phytochemicals in prostate cancer: From bioactive molecules to upcoming therapeutic agents'. En conjunto forman una huella única.

Citar esto